Publications

2013 | 2012 | 2011 | 2010 | Selected Publications
 

2013

Chtarto, A., Bockstael, O., Tshibangu, T., Dewitte, O., Levivier, M. and Tenenbaum, L. (2013). A next step in adeno-associated virus (AAV)- mediated gene therapy for neurological diseases: Regulation and targeting. British Journal of Clinical Pharmacology 76: 217–232

Chtarto, A., Bockstael, O., Gebara, E., Vermoesen, K., Melas, C., Pythoud, C., Levivier, M., Dewitte, O., Luthi-Carter, R., Clinkers, R. and Tenenbaum L. (2013). An adeno-associated virus-based intracellular sensor of pathological Nuclear Factor-kappa B activation for disease-inducible gene transfer. PlosOne 2013;8(1):e53156

Dismuke, D.J., Tenenbaum, L., Samulski, R.J. (2013). Biosafety of Recombinant Adeno-associated Virus Vectors. Curr Gene Ther. 13: 434-452

TOP ^

2012

Bockstael, O., Melas, C., Pythoud, C., Levivier, M., McCarty, D., Samulski, RJ., De Witte, O., Tenenbaum, L. (2012). Rapid transgene expression in multiple precursors cell types of adult rat subventricular zone mediated by adeno-associated type 1 vectors. Hum. Gene Ther. 23: 742-753

TOP ^

2011

Driessens G, Nuttin L, Gras A, Maetens J, Mievis S, Schoore M, Velu T, Tenenbaum L, Préat V, Bruyns C. (2011). Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery. Cancer Immunology, Immunotherapy, 60:273-281.

Vanrell, L., M. di Scala, L. Blanco, I. Otano, V. Baldim, A. Paneda, P. Berraondo, S. Beattie, P. Alzuguren, R. Hernandez, A. Chtarto, L. Tenenbaum, J. Prieto, G. Gonzalez-Aseguinolaza. (2011). Development of a liver specific Tet-On inducible system for AAV vectors, Molecular Therapy, 19:1245-53.

Bockstael, O., K.Foust, B.Kaspar and L.Tenenbaum (2011) Recombinant AAV delivery to the central nervous system. Methods Mol Biol. 807:159-77.
 

TOP ^

2010

Lock, M.,  S. McGorray, A.Auricchio, E. Ayuso, E. J. Beecham, V Blouin-Tavel, M F Bosch-Tubert, M Bose, B Byrne, T Caton, J Chiorini, A Chtarto, K. R Clark , Ts Conlon, C Darmon, M Doria, A Douar, T Flotte, J D. Francis, M.Giacca, M T. Korn, I Korytov, X Leon, B Leuchs, G Kroener-Lux, C Melas, Hi Mizukami, P Moullier, M Müller, K Ozawa, T Philipsberg, K Poulard, C Raupp, C Rivière, S D Roosendaal, R. J Samulski, S M. Soltys, R Surosky, L Tenenbaum, D L. Thomas, B van Montfort, G Veres, J. F Wright, Y Xu, O Zelenaia, L Zentilin and R O Snyder (2010). Characterization of a Recombinant Adeno-Associated Virus Type 2 Reference Standard Material. Hum. Gene Ther 21:1273-85.
 

TOP ^

Selected Publications

Tenenbaum L. , J.L.Darling and E.Hooghe-Peters (1994). Adeno-associated virus (AAV) as a vector for gene transfer into glial cells of the central nervous system. Gene Ther, vol.1, suppl.1,80.

Tenenbaum L., F.Jurysta, A.Stathopoulos, Z.Puschban, C.Melas, W.T.J.M.C. Hermens, J.Verhaagen, B.Pichon, T.Velu and M.Levivier. (2000). Tropism of AAV-2 vectors for neurons of the globus pallidus. NeuroReport, 11,2277-2283.

Tenenbaum L., A. Chtarto, E. Lehtonen, D. Blum , V. Baekelandt, T.Velu, J.Brotchi and M. Levivier (2002). Neuroprotective Gene Therapy for Parkinson’s disease. Curr. Gene Ther. 2, 451-483.

Chtarto A., H.U.Bender, C.O.Hanemann, T.Kemp, E.Lehtonen, M. Levivier , J. Brotchi, T.Velu and L. Tenenbaum (2003. Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther. 10, 86-96.

L.Tenenbaum, E.Lehtonen and P.Monahan. (2003). Evaluation of risks related to the use of adeno-associated virus-based vectors. Curr. Gene Ther. 3: 545-565.

Tenenbaum L., A. Chtarto, E. Lehtonen, T.Velu, J.Brotchi and M. Levivier (2004). Recombinant AAV-mediated gene delivery to the Central Nervous System. J. Gene Med. 6 Suppl 1:S212-22.

Tenenbaum L., M. Peschanski, C.Melas F.Rodesh, E.Lehtonen, A.Stathopoulos, A.Chtarto, T. Velu, J.Brotchi and M. Levivier (2004). Efficient early and sustained transduction of human fetal mesencephalon using AAV2 vectors. Cell Transplant 13, 565-571.

 

TOP ^


Search:
 in this site:
   
   
   
 Rechercher

CHUV - Pavillon 3 - Avenue de Beaumont - CH-1011 Lausanne  - Switzerland  -  Phone +41 21 314 21 20  -  Fax  +41 21 314 08 24